Patent US3676554A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3676554A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-arthritic compositions comprising phosphine or phosphite gold halide complexes and methods of producing anti-arthritic activity

Assignee: Smith Kline & French Laboratories Ltd
•
Filing: 1970-10-30
•
Granted: 1972-07-11
•
Expires: 1990-10-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical compositions having anti-arthritic activity comprising a phosphine or phosphite gold halide complex and methods of producing anti-arthritic activity by administering internally, preferably orally, said compositions.

Inventors

  • 👤 Elizabeth R Mcgusty
  • 👤 Blaine M Sutton
  • 👤 Donald T Walz

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 14:04
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/28; C07F9/50; C07F9/5045

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 12 words
A pharmaceutical composition according to claim 1 in which X is chloro.
Claim 2
Dependent Claim 13 words
A pharmaceutical composition according to claim 2 in which R is lower alkyl.
Claim 3
Dependent Claim 12 words
A pharmaceutical composition according to claim 3 in which R is ethyl.
Claim 4
Dependent Claim 28 words
A pharmaceutical composition according to claim 4 in which the amount of the active medicament is from about 1 mg. to about 5 mg., calculated on gold content.
Claim 5
Independent Claim 75 words
The method of producing anti-arthritic activity which comprises administering orally to an animal organism in an amount sufficient to produce said activity without limiting side effects a phosphine or phosphite gold halide complex of the formula: R3P -> AuX in which: R is lower alkyl, phenyl, lower alkoxy or phenoxy, said lower alkyl and lower alkoxy being straight or branched chain, of from one to three carbon atoms; and X is chloro, bromo or iodo.
Claim 6
Dependent Claim 11 words
The method according to claim 6 in which X is chloro.
Claim 7
Dependent Claim 12 words
The method according to claim 7 in which R is lower alkyl.
Claim 8
Dependent Claim 11 words
The method according to claim 8 in which R is ethyl.
Claim 9
Dependent Claim 31 words
The method according to claim 9 in which the active medicament is administered in a daily dosage regimen of from about 1 mg. to about 10 mg., calculated on gold content.

References Cited (Backward Citations)

US2451841A Cited
US2607789A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-07-11 1976-01-10 1976-07-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-07-11 1980-01-10 1980-07-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-07-11 1984-01-10 1984-07-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag